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Background. Although the causal relationship betweenHelicobacter pylori infection and the development of gastric cancer is firmly
established, the exact nature of the pathogenicity factors of H. pylori that predispose to gastric oncogenesis remains incompletely
characterized. We investigated the association between H. pylori virulence genotypes and disease in a well-characterized cohort
consisting of 109H. pylori isolates from gastric biopsies originating frompatients.Methods.The prevalence of genotypewas assessed
by PCR and related to clinical histopathological parameters. Results. The relation of babA2 and babB negative and iceA1 positive
genotype as a single genotype and the development of cases toGCwas statistically significant (𝑃 < 0.001).The cagE, cagA, and iceA1
were found more commonly in patients with GC as compared with the other groups. The relation of the presence of iceA1 and the
development of cases to GCwas statistically significant (𝑃 = 0.008), but babA2 and babB alleles were not detected in these patients.
These apparent negative associations were still statically significant (𝑃 = 0 and 0.005). Conclusion. Our results show an elevated
prevalence of infection with H. pylori strains carrying known virulence genotypes with high genetic diversity. This highlights the
importance of identifying gene variants for an early detection of virulent genotypes.
1. Introduction
Gastric cancer remains a prevalent disease worldwide with
a poor prognosis. Helicobacter pylori plays a major role
in gastric carcinogenesis. H. pylori colonization leads to
chronic gastritis, which predisposes to atrophic gastritis,
intestinalmetaplasia, dysplasia, and eventually gastric cancer.
Screening, treatment, and prevention of H. pylori coloniza-
tion can reduce the incidence of gastric cancer [1]. Other
interventions that may yield a similar effect, although of
smaller magnitude, include promotion of a healthy lifestyle
including dietary measures, nonsmoking, low alcohol intake,
and sufficient physical activity [2]. Furthermore, increasing
evidence suggests that host factors, including genetic make-
up, are also important determinants for carcinogenesis in H.
pylori infection [3]. Colonization of H. pylori has been asso-
ciated with chronic gastritis because it can trigger fulminant
inflammatory response which can lead to pathological condi-
tions such as gastric carcinoma and peptic ulcer disease [4].
Consequently a clinical need exists to stratify H. pylori-
infected patients with respect to their propensity to develop
H. pylori-related pathology; especially for GC this is felt as
a pressing concern. The importance of H. pylori virulence
factors is evident from the serious clinical outcome associated
with bacteria positive for the vacillating cytotoxic (vacA) and
the cytotoxin-associated gene A (cagA) antigen [5]. However,
these two virulence factors are insufficient to explain the
variety in clinical presentation of pathology associates with
H. pylori infection [6, 7]. A potentialH. pylori virulence factor
possibly important to explain this variance in clinical out-
come is the cag pathogenicity island (cag-PAI).The cagA gene
is a marker for the presence of the cag-PAI of approximately
40 kb, whose presence is associated with the more severe
clinical outcomes [8, 9]. A type IV secretion system translo-
cates cagA protein into gastric epithelial cells, where it is
phosphorylated.When this modification occurs, cagA affects
various cellular processes and signal transduction pathways,
such as disruption of tight and adherent junctions that lead
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Table 1: Primer sequences for polymerase chain reaction.
Gene Primer Nucleotide sequence Size (bp) Reference
ureC (glmM) Hp-F GGATAAGCTTTTAGGGGTGTTAGGGG 294 [13]
HP-R GCTTACTTTCTAACACTAACGCGC
cagE cagE-F TTGAAAACTTCAAGGATAGGATAGAGC 508 [12]
cagE-R GCCTAGCGTAATATCACCATTACCC
babA2 babA2-F CCAAACGAAACAAAAAGCGT 271 [6]
babA2-R GCTTGTGTAAAAGCCGTCGT
babB babB -F ATGAAAAAAACCCTTTTAC 496 [14]
babB-R CGAATTGCAAGTGATGGT
cagA cagA-F AGGGATAACAGGCAAGCTTTTGA 352 [15]
cagA-R CTGCAAAAGATTGTTTGGCAGA
iceA1 iceA1-F GTGTTTTTAACCAAAGTATC 247 [13]
iceA1-R CTATAGCCASTYTCTTTGCA
iceA2 iceA2-F GTTGGGTATATCACAATTTAT 229 [13]
iceA2-R TTRCCCTATTTTCTAGTAGGT
to proinflammatory and mitogenic responses: effects [8, 10].
One of the six cag-PAI genes is cagE, located in the right half
of the cag-PAI, that has been shown to induce secretion of
interleukin- (IL-) 8, from infected host epithelial cells [11, 12].
Another putative virulence factor is iceA, whose gene has
two main allelic variants, iceA1 and iceA2. The expression
of iceA1 is upregulated on contact of H. pylori with human
epithelial cells and may be linked with peptic ulcer disease
[16, 17]. The blood group antigen binding adhesin (babA), a
78KDa outer membrane protein encoded by the babA2 gene,
binds to Lewis b antigens and ABO antigen [18, 19]. Although
three bab alleles have been identified (babA1, babA2, and
babB), only the babA2 gene product is functionally active
[20]. Studies inWestern populations have associated the pres-
ence of the babA2 gene with gastric cancer [19, 21].The aim of
this study is to assess the genotype ofH. pylori strains infect-
ing patients with chronic gastritis through the evaluation of
the prevalence of several genes coding for virulence factors.
2. Materials and Methods
This research was approved by the regional Medical Research
Ethics Committee of Azad University of Medical Science on
19 Jul 2016 (number 1311/28772) and all patients provided
written informed consent for this research.
This study protocol conforms to the ethical guidelines
of the 1975 Declaration of Helsinki as reflected in a prior
approval by the institution’s human research committee.
2.1. Patients, Bacterial Strains, and Cultivation. Our cohort
consisted of 109 clinical isolates of H. pylori; 49 (45%) were
from females and 60 from males (55%).
From male patients (sex ratio F/M: 0.82), the average age
of the patients from which the isolates were obtained was
39±17 years.H. pyloriwas isolated employing gastric biopsies
of patients presenting with gastritis, peptic ulcer, or gastric
cancer. Patients were not exposed to antimicrobial agents at
least one week before endoscopy was performed. Following
collection, gastric biopsy samples were homogenized and
cultured onto Brucella agar supplanted with 5% sheep blood
and antibiotics (vancomycin, amphotericin B, and trimetho-
prim). Culture plates were incubated at microaerophilic
condition, 37∘C and high humidity for 5–7 days. Organisms
were identified as H. pylori based on colony morphology,
gram staining, and positive oxidase, catalase, and urease tests.
2.2. DNA Extraction from Culture. Genomic DNA of totalH.
pylori isolates was extracted using the QiAamp DNA mini
kit (QIAGEN,Hilden,Germany) according tomanufacturer’s
protocol and stored at −20∘C until use.
2.3. Detection of Genes. In this study, PCR was used to
detect the H. pylori specific ureC gene for confirming that
the cultures represented a bona-fide H. pylori isolate, and
the same technique was employed to establish presence or
absence of cagE, cagA, iceA1, iceA2 babA2, and babB genes.
All primer sets were selected from published literature
(listed in Table 1). PCR reactions were performed in a
volume of 50 𝜇L containing 10mmol/L Tris-HCl, 1.5mmol/L
MgCl
2
, 0.2mmol/L of each deoxynucleotide, 25 pmol of each
primer, and 2.5 units of Taq polymerase (Geneone, Germany)
[22, 23]. The thermal cycler program used consisted of
the following steps: initial denaturation at 94∘C for 3min
followed by 35 cycles of 30 seconds at 94∘C (denaturation); 30
seconds at 58∘C for cagA and glmM [24]; 30 seconds at 53∘C
for cagE; 48∘C for babA2; 49∘C for babB; 57∘C for iceA1; and
48∘Cand for iceA2 all annealing steps, followed by 30 seconds
at 72∘C (extension step); and a final extension step was 3min
at 72∘C [25].
2.4. Statistics Analysis. Data were analyzed by SPSS version
16. Fisher’s exact test or the Chi-square test was used for
analysis of categorical data. A𝑃 value of<0.05was considered
statistically significant.
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Table 2: Relationship between clinical outcome and status of cagE, babA2, babB, iceA1, iceA2, and CagA.
Genotypes Number (%) of isolates Total (𝑛 = 109) 𝑃 value
NUD (𝑛 = 81) PUD (𝑛 = 19) GC (𝑛 = 9)
cagE 40 (49.4%) 13 (68.4%) 8 (88.9%) 61 (55.9%) 0.198
babA2 60 (74%) 16 (84.2%) 0 76 (71.7%) 0.001
babB 53 (65.4%) 12 (63.1%) 0 65 (61.3%) 0.005
iceA1 29 (35.8%) 8 (42.1%) 9 (100%) 46 (42.2%) 0.008
iceA2 11 (13.6%) 3 (15.8%) 0 14 (13.2%) 0.779
cagA 53 (65.4%) 15 (78.9%) 9 (100%) 77 (70.6%) 0.134
NUD: nonulcer dyspepsia; PUD: peptic ulcer disease; GC: gastric cancer; Pv: 𝑃 value.
3. Results
3.1. Description of the Patient Cohort and Isolation of Study
Samples. A total of 109 H. pylori samples were isolated from
an initial number of 359 biopsies included in this study
(yielding an apparent infection rate of 30.4%), of which 60
(55%) were derived from male patients and 49 (45%) isolates
came from female patients (sex ratio F/M: 0.82). The average
patients’ age at the time of endoscopy was 39 ± 17 years.
From the 109 patients with established H. pylori infection, 81
patients had presented with a nonulcer dyspepsia, nineteen
patients with a peptic ulcer dyspepsia, and nine patients
with GC (Signet Ring Cell Carcinoma (SRCC)). There was
no significant difference between the mean age and sex of
patients with and without ulcers and cancer. We concluded
that our cohort would enable analysis of the link between H.
pylori virulence factors and clinical presentation.
3.2. The Presence of Virulence Factors Is Common in the
Clinical Cohort. The PCR-based amplification showed that
the cagE, babA2, and babB positive strains had a prevalence
of, respectively, 55.9%, 71.7%, and 61.3% in our cohort,
whereas cagA, iceA1, and iceA2were detected in, respectively,
70.6%, 42.2%, and 13.2% of the patients included in this study
(Table 2).Thus, the virulence factors selected for this study are
commonly detected in our patient cohort and allow statistical
analysis as to their relation to disease manifestation.
3.3. Specific H. pylori Virulence Factors Show Trends of
Being Positively or Negatively Associated with Patient’s Clinical
Presentation. In our study the frequency of cagE-positive
isolates obtained from patients with nonulcer dyspepsia,
peptic ulcer dyspepsia, or GC patients was 49.4%, 68.4%,
and 88.9%, respectively, but this apparent positive association
with more severe disease did not reach statistical significance
(𝑃 = 0.198). The babA2 genotype was detected in 74%,
84.2%, and 0% of isolates from NUD, PUD, and GC patients.
The percentage of babA2− genotype within GC patients was
significantly higher than that of cagA+ genotype (𝑃 < 0.001).
Also the percentage of babB+ was 65.4% and 63.1% for
NUD and PUD cases, respectively, but for isolates from
patients with GC (0%), this apparent negative association
was statistically significant (𝑃 = 0.005). Conversely the
prevalence of the iceA2 allele was observed in NUD patients
(13.6%) and in PUD (15.8%) and in GC patients (0%), but no
significant association was observed between iceA2 genotype
and GC (𝑃 = 0.779). Similarly, in this study the distribution
of iceA1 and clinical outcome was analyzed statistically and
it was observed that the frequency of iceA1-positive isolates
in NUD, PUD, and GC patients was 35.8%, 42.1%, and
100%, respectively. The relation of the presence of iceA1 and
the development of cases to gastric cancer was statistically
significant (𝑃 = 0.008).
Although the cagA allele was observed in NUD (65.4%)
cases and in PUDpatients (78.9%) and inGCpatients (100%),
there was not statistically significant association between
cagA and the gastric outcomes (𝑃 = 0.134). A full overview
of all virulence factors studied and their linkage to specific
clinical manifestations is provided through Table 2.
It is apparent from our data that cagE, cagA, and iceA1
are more common in patients with gastric cancer than in the
other patient groups, whereas babA2 and babB alleles were
absent in patients with GC.
3.4. Combining Different Virulence Factors Allows Stratifica-
tion of the Patient Cohort with respect to Patient Stratification.
We examined eight different combinations based on analysis
of babA2, babB, and iceA1 genotypes (positive and negative)
in patients as a single genotype (Table 3). We were able to
identify an association between these genotypes and clinical
outcome. The frequency distributions of the combination
genotypes ofH. pylori showed the relation of babA2 and babB
negative and iceA1 positive genotype and the development of
cases to gastric cancer was statistically significant (𝑃 < 0.001)
among the patient groups. But there was not statistically
significant association between other genotype combinations
and the gastric cancer (𝑃 ≥ 0.113).
The apparent absence of babA2 and babB alleles in
GC patients raises, however, hopes that larger studies may
establish the usefulness of these alleles in guiding patient
management.
4. Discussion
Various studies have observed substantial differences in inci-
dence and/or severity of gastroduodenal pathologies related
to H. pylori which may vary according to geographical
regions [26]. Although many factors may contribute to these
differences, an obvious contributing factor is the different
distribution of pathogenicmarkers in circulating strains [27].
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Table 3: Combination of babA2, babB, and iceA1 genotypes and clinical outcome.
babA2 babB iceA1 GC (𝑛 = 9) NUD (𝑛 = 81) PUD (𝑛 = 19) Total (𝑛 = 109) 𝑃 value
Positive Positive Positive 0 19 6 25 0.113
Positive Positive Negative 0 15 3 18 0.121
Positive Negative Positive 0 12 2 14 0.136
Positive Negative Negative 0 9 4 13 0.196
Negative Positive Positive 3 7 1 11 0.216
Negative Positive Negative 0 11 2 13 0.157
Negative Negative Positive 6 3 1 10 0.001
Negative Negative Negative 0 5 0 5 0.253
Presence of a gene = positive; absence of a gene = negative; Pv: 𝑃 value.
The clinical relevance of the putative virulence-associated
genes of H. pylori and geographical region remains contro-
versial. Other factors that influence the risks for atrophy
and cancer in the presence of infection may be related to
the time when infection occurred, to other environmental
factors, and to the host genetic variation [28]. In particular
single nucleotide polymorphisms in genes that influence
bacterial handling via pattern recognition receptors appear to
be involved, further strengthening the link between host risk
factors, H. pylori incidence, and cancer [29]. In the present
study we exploited this situation to study the relationship
between selected virulence genes of H. pylori and the clinical
status. Our results clearly support the notion that further
studies aimed at establishing the negative predictive value of
the presence of babA2 and babB alleles for GC development
are warranted.
The cagE is a pathogenicity biomarker of H. pylori. A
survey of previous studies suggested that the cagE prevalence
is different around the world [30]. The general importance of
cagE is best illustrated by its high frequency in GC patients
as demonstrated by studies performed in patient populations
derived from India (100%), Turkey (81.8%), and Thailand
(93.8%) [31]. However, the prevalence of cagE gene in this
study was only 55.9%, markedly different from the results
obtained in the aforementioned countries [32]. In the present
study cagE-positive isolates were slightly more detected in
isolates from peptic ulcer dyspepsia (PUD) patients (68.4%),
but the potential significance of this finding, if any, remains
to be established. The prevalence of cagA gene in our cohort
is 70.6%, which resembles the situation in Western countries
(Yamaoka et al., 2002), but is markedly lower than that
observed in East Asian countries where cagA is present in
more than 90%of cases [32]. Like cagE, cagA-positive isolates
were enriched in samples obtained from peptic ulcer dyspep-
sia patients, albeit not in a statistically significant manner.
Nevertheless, our findings support previous studies [32] (Wu
et al., 2003) and should prove interesting in including our
data in a meta-analysis of virulence genes in this respect.
Our results show that the prevalence of iceA1 and iceA2
genes in isolates was 42.2% and 13.2%, respectively. These
results are in agreement with previous studies showing that
the iceA1 gene is prevalent in Japanese, Korean, and Dutch
patients [13] (Ito et al., 2000; Shiota et al., 2013); conversely
the iceA2 allele was predominant in the United States and
Colombia. In our cohort, the relation of the presence of
iceA1 and the development of cases to gastric cancer was
statistically significant (𝑃 = 0.008). But our data showed that
there was no significant association between iceA2 and GC
compared with PUD or NUD. However, several studies have
reported different results, as the iceA2 genewas detected to be
predominant genotype in these studies (Aghdam et al., 2014;
Biernat et al., 2014).
The babA is one of the mediators for the attachment
to gastric cells by H. pylori [33]. More recent analysis of
babA2 as a virulence marker has produced conflicting data
on the usefulness of babA2 expression in predicting clinical
outcome, which is most likely dependent on the geographic
origin of the H. pylori strains. Survey of previous studies on
Portuguese, Thai, and India populations showed that babA2
is not a marker for peptic ulcer disease or gastric cancer
[12, 26, 34]. However, several studies have reported different
results for strains isolated from Turkey or Germany [26, 35].
Our study suggests that babA2, “although quite prevalent,” is
associated with reduced propensity to develop GC and is thus
associated with less oncogenic H. pylori. Similar results were
obtained concerning babB.
Our results showed the relation of babA2 and babB
negative and iceA1 positive genotype and the development
of cases to gastric cancer was statistically significant. Further
studies are required to determine the functions of babA2
and babB and their relationship with disease outcome and
whether the presence of these alleles indicates the presence
of bacteria unlikely to confer progression towards GC.
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